Local pushIncentives for local drugs
Industry ReportHealthcare
Nigeria Pharmaceutical Manufacturing Industry Report 2026
Capacity, product portfolios, API sourcing, regulation and outlook
Why now. Exits by multinationals and new incentives for local production are reshaping the industry. Local makers are scaling up, but raw materials remain imported.
- Chapters
- 16
- Edition
- 2026
- Forecast
- 2026 to 2031
- Coverage
- Nigeria, 36 states and FCT
Table of Contents
What is inside this report
The full contents of the Nigeria Pharmaceutical Manufacturing Industry Report 2026. Each chapter is backed by data tables and charts, with state-level detail where the data allows.
- 01
About the industry
- Definition of the Pharmaceutical Manufacturing industry
- Industry classification (ISIC and NBS sector codes)
- What is included and excluded
- Value chain from inputs to end users
- Related industries
- Key terms and definitions
- 02
Industry at a glance
- Executive summary
- Key statistics, 2026: revenue, output, businesses and employment
- Major players at a glance
- Products and services at a glance
- Key external drivers
- SWOT analysis
- Industry structure scorecard: life cycle, concentration, barriers, regulation, volatility
- 03
Industry performance
- Performance snapshot: revenue, employment, businesses and profit margin, 2021 to 2026
- Current performance and what drove it
- Capacity and utilisation
- Volatility
- Contribution to GDP
- Industry life cycle
- 04
Products and markets
- Product segment: Generic medicines
- Product segment: Over-the-counter products
- Product segment: Intravenous fluids
- Product segment: Vaccines and biologics
- Major markets: Hospitals and pharmacies, Government procurement, Export markets in ECOWAS
- Imports, exports and trade balance
- Local production versus imports
- 05
Geographic breakdown
- Business and plant locations by state
- South-West, North, South-South and South-East clusters
- Lagos, FCT and other key hubs
- Location factors: ports, power, raw materials and markets
- 06
Competitive forces
- Market concentration
- Barriers to entry: licensing, capital and start-up costs
- Substitute products and services
- Buyer and supplier power
- Informal and unregistered operators
- 07
Companies and competitive landscape
- Profile: Listed local manufacturers
- Profile: Multinational subsidiaries
- Profile: Mid-sized local producers
- Market share estimates
- Recent investments, expansions, mergers and acquisitions
- 08
External environment
- Exchange rate, inflation and interest rates
- Household incomes and business spending
- Energy and power costs
- Regulation and policy
- Government assistance and incentives
- Industry associations
- 09
Financial benchmarks
- Cost structure: purchases, wages, energy, rent, depreciation and marketing
- Profit margins
- Income statement and balance sheet benchmarks
- Liquidity, coverage, leverage and operating ratios
- Industry tax structure: CIT, VAT and sector levies
- 10
Industry economics and operating structure
- Key input: Active ingredients (APIs)
- Key input: Power and production costs
- Key input: Distribution
- Pricing mechanisms
- Supply chain and distribution
- Capital and working capital requirements
- Employment and wages
- 11
Key statistics
- Industry data, 2021 to 2031: revenue, output, establishments, employment and wages
- Annual percentage change
- Imports, exports and domestic consumption
- Prices and price indices
- 12
Key success factors
- Scale and capacity utilisation
- Access to inputs, foreign exchange and finance
- Energy cost control
- Distribution reach and customer relationships
- Regulatory compliance
- 13
Risks and challenges
- API import dependence
- FX and costs
- Counterfeit competition
- Macroeconomic and currency risk
- 14
Opportunities
- Opportunity: policy incentives
- Opportunity: multinational exits leaving gaps
- Opportunity: regional export demand
- Import substitution and ECOWAS export potential under AfCFTA
- 15
Industry outlook
- Five-year forecast, 2026 to 2031: revenue, output and establishments
- Investment pipeline
- Risks to the forecast
- What to watch
- 16
Appendix: methodology and definitions
- Research methodology and estimation
- Data sources: NBS, CBN, regulators and STATART field data
- Definitions and abbreviations
- Supporting tables
Need this report?
Request your copy and our team will reach out personally with the latest edition and delivery details.
